§ 13F · FUND PROFILE
Rosalind Advisors, Inc..
AUM · $269M (13F)Positions · 35Turnover · n/a · Q2Filed · Aug 14, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
+$7M deployed
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS
The book · Q2 2026
FILED AUG 14, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q2 |
|---|---|---|---|---|---|---|
| 1 | DCTH | DELCATH SYSTEMS, INC. | 3.30M | $42M | 15.4% | ±0% |
| 2 | FENC | FENNEC PHARMACEUTICALS INC | 3.19M | $34M | 12.7% | +10% |
| 3 | XERS | XERIS BIOPHARMA HOLDINGS INC | 2.91M | $23M | 8.6% | −10% |
| 4 | SVRA | SAVARA INC | 3.18M | $20M | 7.3% | −1% |
| 5 | VSTM | VERASTEM INC | 3.99M | $15M | 5.7% | +86% |
| 6 | XFOR | X4 PHARMACEUTICALS INC | 3.21M | $15M | 5.6% | ±0% |
| 7 | EYPT | EYEPOINT PHARMACEUTICALS INC | 988K | $14M | 5.2% | −5% |
| 8 | HELP | CYBIN INC | 1.96M | $13M | 4.8% | +28% |
| 9 | VOR | VOR BIOPHARMA INC | 649K | $12M | 4.4% | −7% |
| 10 | PCVX | VAXCYTE INC | 200K | $12M | 4.3% | −31% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE ROSALIND SIGNAL
AC read
Rosalind Advisors, Inc. is a Other fund managing $269 million in assets. The fund runs a portfolio of 35 positions.
Read the full dossier →